naltrexone and Kahler Disease

naltrexone has been researched along with Kahler Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Howells, RD; Mundra, JJ; Terskiy, A	1

Other Studies

1 other study(ies) available for naltrexone and Kahler Disease

Article	Year
Naltrindole inhibits human multiple myeloma cell proliferation in vitro and in a murine xenograft model in vivo. The Journal of pharmacology and experimental therapeutics, 2012, Volume: 342, Issue:2 Topics: Animals; Antineoplastic Agents; Binding Sites; Bone Marrow; Cell Line, Tumor; Cell Proliferation; Extracellular Signal-Regulated MAP Kinases; HEK293 Cells; Humans; Mice; Mice, SCID; Multiple Myeloma; Naltrexone; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptors, Opioid; Xenograft Model Antitumor Assays	2012

Article

Year

Naltrindole inhibits human multiple myeloma cell proliferation in vitro and in a murine xenograft model in vivo.

The Journal of pharmacology and experimental therapeutics, 2012, Volume: 342, Issue:2

Topics: Animals; Antineoplastic Agents; Binding Sites; Bone Marrow; Cell Line, Tumor; Cell Proliferation; Extracellular Signal-Regulated MAP Kinases; HEK293 Cells; Humans; Mice; Mice, SCID; Multiple Myeloma; Naltrexone; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptors, Opioid; Xenograft Model Antitumor Assays

2012